Latest Content

Cobenfy gains NMPA approval in China, offering a groundbreaking treatment for schizophrenia with a unique mechanism and improved symptom management.

In this CME article, explore effective strategies for managing sleep disturbances in elite athletes, focusing on pharmacologic and nonpharmacologic interventions.

Reviva Pharmaceuticals announced FDA recommendations from their pre-NDA meeting on brilaroxazine for schizophrenia.

Discover engaging holiday reads that blend entertainment with profound insights, featuring classics and modern works that explore the human psyche.

An open letter urges lawmakers to regulate AI chatbots, highlighting their dangers to children's emotional development and mental health.

Let's examine the vital intersection of religion, spirituality, and mental health, revealing their powerful role in enhancing patient care and well-being.

The tragedy sheds light on the complexities of parricide and loss.

Discover how access to nature enhances mental health, promoting healing and resilience through green spaces and innovative therapeutic practices.

Explore the legacies of Milwaukee's influential psychiatrists, Jon Gudeman and Scott Sandage, and their impact on mental health and culture.

Vistagen's fasedienol fails to show significant efficacy in treating social anxiety disorder, despite favorable safety data from the PALISADE-3 trial.

Explore innovative strategies for managing schizophrenia, focusing on novel treatments that address negative and cognitive symptoms beyond traditional antipsychotics.

Explore Irvin D. Yalom's impactful insights on psychotherapy, revealing the emotional dynamics between therapist and patient in transformative narratives.